Loading clinical trials...
Loading clinical trials...
Pilot study data have demonstrated that peanuts ameliorate the postprandial glucose and insulin response when incorporated into an acute high fat/high glucose meal. However, it is unclear whether acute consumption of peanuts can also influence vascular function. This study will therefore evaluate the effects of acute peanut consumption on vascular function, glycemic control, and plasma lipids. The hypothesis is that that addition of peanuts to a high fat/high glucose meal will reduce the production of triglycerides, glucose, and improve endothelial function as measured by flow-mediated dilation (FMD).
Age
20 - 50 years
Sex
MALE
Healthy Volunteers
Yes
Penn State University
University Park, Pennsylvania, United States
Start Date
August 1, 2011
Primary Completion Date
May 1, 2014
Completion Date
June 1, 2014
Last Updated
August 21, 2023
20
ESTIMATED participants
Control
DIETARY_SUPPLEMENT
Peanut
DIETARY_SUPPLEMENT
Lead Sponsor
Penn State University
Collaborators
NCT03372733
NCT07241390
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06909773